KAMADA LTD (KMDA) Stock Fundamental Analysis
USA - NASDAQ:KMDA - IL0010941198 - Common Stock
6.87 USD
+0.02 (+0.29%)
KMDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. While KMDA has a great profitability rating, there are some minor concerns on its financial health. KMDA may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make KMDA suitable for value investing!
1. Profitability
1.1 Basic Checks
KMDA had positive earnings in the past year.
In the past year KMDA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
KMDA has a better Return On Assets (5.16%) than 91.57% of its industry peers.
With an excellent Return On Equity value of 7.31%, KMDA belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
KMDA's Return On Invested Capital of 6.18% is amongst the best of the industry. KMDA outperforms 93.26% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 15.49%.
The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(6.18%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROIC | 6.18% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of KMDA (11.21%) is better than 92.51% of its industry peers.
In the last couple of years the Profit Margin of KMDA has declined.
With an excellent Operating Margin value of 14.89%, KMDA belongs to the best of the industry, outperforming 93.45% of the companies in the same industry.
In the last couple of years the Operating Margin of KMDA has declined.
With a decent Gross Margin value of 43.62%, KMDA is doing good in the industry, outperforming 74.53% of the companies in the same industry.
In the last couple of years the Gross Margin of KMDA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
Compared to 1 year ago, KMDA has about the same amount of shares outstanding.
KMDA has more shares outstanding than it did 5 years ago.
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
KMDA has an Altman-Z score of 3.25. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.25, KMDA is doing good in the industry, outperforming 69.66% of the companies in the same industry.
KMDA has a debt to FCF ratio of 0.36. This is a very positive value and a sign of high solvency as it would only need 0.36 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.36, KMDA belongs to the best of the industry, outperforming 95.69% of the companies in the same industry.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
KMDA's Debt to Equity ratio of 0.04 is in line compared to the rest of the industry. KMDA outperforms 41.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Altman-Z | 3.25 |
ROIC/WACC0.71
WACC8.69%
2.3 Liquidity
A Current Ratio of 4.00 indicates that KMDA has no problem at all paying its short term obligations.
The Current ratio of KMDA (4.00) is comparable to the rest of the industry.
A Quick Ratio of 2.21 indicates that KMDA has no problem at all paying its short term obligations.
The Quick ratio of KMDA (2.21) is worse than 70.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.93% over the past year.
The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
Looking at the last year, KMDA shows a quite strong growth in Revenue. The Revenue has grown by 9.67% in the last year.
Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)25.93%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%62.5%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%5.37%
3.2 Future
KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.77% yearly.
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 9.34% on average per year.
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.21, which indicates a rather expensive current valuation of KMDA.
Based on the Price/Earnings ratio, KMDA is valued cheaper than 95.13% of the companies in the same industry.
KMDA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.91 indicates a correct valuation of KMDA.
94.19% of the companies in the same industry are more expensive than KMDA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (22.92), we can say KMDA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.21 | ||
| Fwd PE | 15.91 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaper than 97.00% of the companies in the same industry.
97.19% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.54 | ||
| EV/EBITDA | 8.53 |
4.3 Compensation for Growth
KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
KMDA's earnings are expected to grow with 30.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y28.87%
EPS Next 3Y30.77%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.91%.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 93.65. KMDA pays more dividend than 98.88% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, KMDA pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y28.87%
EPS Next 3Y30.77%
NASDAQ:KMDA (10/24/2025, 8:00:02 PM)
6.87
+0.02 (+0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners10.9%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap396.26M
Revenue(TTM)169.52M
Net Income(TTM)19.01M
Analysts84.44
Price Target16.32 (137.55%)
Short Float %0.12%
Short Ratio0.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.66%
Min EPS beat(2)1.67%
Max EPS beat(2)45.66%
EPS beat(4)4
Avg EPS beat(4)19.74%
Min EPS beat(4)1.67%
Max EPS beat(4)45.66%
EPS beat(8)7
Avg EPS beat(8)31.91%
EPS beat(12)10
Avg EPS beat(12)19.39%
EPS beat(16)10
Avg EPS beat(16)-93.5%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)2.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.79%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)5
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)8.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.78%
EPS NY rev (1m)9.29%
EPS NY rev (3m)16.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.21 | ||
| Fwd PE | 15.91 | ||
| P/S | 2.34 | ||
| P/FCF | 12.54 | ||
| P/OCF | 9.88 | ||
| P/B | 1.52 | ||
| P/tB | 1.73 | ||
| EV/EBITDA | 8.53 |
EPS(TTM)0.34
EY4.95%
EPS(NY)0.43
Fwd EY6.29%
FCF(TTM)0.55
FCFY7.97%
OCF(TTM)0.7
OCFY10.12%
SpS2.94
BVpS4.51
TBVpS3.98
PEG (NY)0.4
PEG (5Y)N/A
Graham Number5.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROCE | 7.83% | ||
| ROIC | 6.18% | ||
| ROICexc | 7.78% | ||
| ROICexgc | 8.82% | ||
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% | ||
| FCFM | 18.63% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 58.03% | ||
| Cap/Sales | 5.03% | ||
| Interest Coverage | 35.45 | ||
| Cash Conversion | 100.46% | ||
| Profit Quality | 166.16% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 | ||
| Altman-Z | 3.25 |
F-Score6
WACC8.69%
ROIC/WACC0.71
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.93%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%62.5%
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue 1Y (TTM)9.67%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%5.37%
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
EBIT growth 1Y50%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.93%
EBIT Next 3Y35.01%
EBIT Next 5YN/A
FCF growth 1Y387.49%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y257.57%
OCF growth 3YN/A
OCF growth 5Y11.54%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
Can you provide the valuation status for KAMADA LTD?
ChartMill assigns a valuation rating of 8 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
Can you provide the financial health for KMDA stock?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.
Can you provide the expected EPS growth for KMDA stock?
The Earnings per Share (EPS) of KAMADA LTD (KMDA) is expected to grow by 50.06% in the next year.